These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23757870)

  • 1. [Comparison of effects of two anticoagulants on hidden blood loss after total hip arthroplasty].
    Li J; Zhou Y; Jing J; Zhan J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Apr; 27(4):432-5. PubMed ID: 23757870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of rivaroxaban and enoxaparin on blood loss after total knee arthroplasty].
    Li J; Jing J; Zhou Y; Yao Y; Zhan J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Jan; 28(1):26-9. PubMed ID: 24693773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Case-control study on effect of rivaroxaban on the risk of hidden bleeding after total hip arthroplasty].
    Li J; Jing JH; Shi ZJ; Zhou Y
    Zhongguo Gu Shang; 2014 Jan; 27(1):34-7. PubMed ID: 24754142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies.
    Turpie AG; Lassen MR; Eriksson BI; Gent M; Berkowitz SD; Misselwitz F; Bandel TJ; Homering M; Westermeier T; Kakkar AK
    Thromb Haemost; 2011 Mar; 105(3):444-53. PubMed ID: 21136019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of ivaroxaban on hidden blood loss and blood transfusion rate after primary total knee arthroplasty].
    Wang G; Zhang Y; Zhao X; Zhang Y; Wang L; Kong Y
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2012 Nov; 26(11):1306-9. PubMed ID: 23230662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of rivaroxaban on risk of bleeding after total knee arthroplasty].
    Li J; Wang J; Li Y; Shi Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2011 Nov; 25(11):1323-5. PubMed ID: 22229185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboprophylaxis after minimally invasive total knee arthroplasty: a comparison of rivaroxaban and enoxaparin.
    Yen SH; Lin PC; Kuo FC; Wang JW
    Biomed J; 2014; 37(4):199-204. PubMed ID: 25116715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement.
    Eriksson BI; Borris LC; Dahl OE; Haas S; Huisman MV; Kakkar AK; Muehlhofer E; Dierig C; Misselwitz F; Kälebo P;
    Circulation; 2006 Nov; 114(22):2374-81. PubMed ID: 17116766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enoxaparin versus dabigatran or rivaroxaban for thromboprophylaxis after hip or knee arthroplasty: Results of separate pooled analyses of phase III multicenter randomized trials.
    Huisman MV; Quinlan DJ; Dahl OE; Schulman S
    Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):652-60. PubMed ID: 20923996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of complications requiring return to theatre in hip and knee arthroplasty patients taking enoxaparin versus rivaroxaban for thromboprophylaxis.
    Chahal GS; Saithna A; Brewster M; Gilbody J; Lever S; Khan WS; Foguet P
    Ortop Traumatol Rehabil; 2013; 15(2):125-9. PubMed ID: 23652532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant use of medication with antiplatelet effects in patients receiving either rivaroxaban or enoxaparin after total hip or knee arthroplasty.
    Eriksson BI; Rosencher N; Friedman RJ; Homering M; Dahl OE
    Thromb Res; 2012 Aug; 130(2):147-51. PubMed ID: 22225858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interpretation of benefit-risk of enoxaparin as comparator in the RECORD program: rivaroxaban oral tablets (10 milligrams) for use in prophylaxis in deep vein thrombosis and pulmonary embolism in patients undergoing hip or knee replacement surgery.
    Van Thiel D; Kalodiki E; Wahi R; Litinas E; Haque W; Rao G
    Clin Appl Thromb Hemost; 2009; 15(4):389-94. PubMed ID: 19608550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of posterolateral conventional and minimally invasive total hip arthroplasty].
    Sun S; Wang S; Zhao L; Wang X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Jun; 23(6):641-3. PubMed ID: 19594003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of tranexamic acid on blood loss after primary cementless total hip replacement with rivaroxaban thromboprophylaxis: A case-control study in 70 patients.
    Clavé A; Fazilleau F; Dumser D; Lacroix J
    Orthop Traumatol Surg Res; 2012 Sep; 98(5):484-90. PubMed ID: 22542983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of rivaroxaban on the complications of surgery after total hip or knee replacement: results from the RECORD programme.
    Lassen MR; Gent M; Kakkar AK; Eriksson BI; Homering M; Berkowitz SD; Turpie AG
    J Bone Joint Surg Br; 2012 Nov; 94(11):1573-8. PubMed ID: 23109641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost and outcomes associated with rivaroxaban vs enoxaparin for the prevention of postsurgical venous thromboembolism from a US payer's perspective.
    Duran A; Sengupta N; Diamantopoulos A; Forster F; Kwong L; Lees M
    J Med Econ; 2011; 14(6):824-34. PubMed ID: 22023098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty.
    Eriksson BI; Borris LC; Friedman RJ; Haas S; Huisman MV; Kakkar AK; Bandel TJ; Beckmann H; Muehlhofer E; Misselwitz F; Geerts W;
    N Engl J Med; 2008 Jun; 358(26):2765-75. PubMed ID: 18579811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of minor bleeding complications using dabigatran or enoxaparin after cemented total hip arthroplasty.
    Gombár C; Horvath G; Gálity H; Sisák K; Tóth K
    Arch Orthop Trauma Surg; 2014 Apr; 134(4):449-57. PubMed ID: 24488447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of hemostatic effect and safety in primary unilateral total hip arthroplasty receiving different anticoagulants after anti-fibrinolysis with tranexamic acid].
    Deng Z; Sheng P; Xu D; Fu M; He A; Liao W; Kang Y
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2020 Dec; 34(12):1561-1567. PubMed ID: 33319536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement.
    Eriksson BI; Kakkar AK; Turpie AG; Gent M; Bandel TJ; Homering M; Misselwitz F; Lassen MR
    J Bone Joint Surg Br; 2009 May; 91(5):636-44. PubMed ID: 19407299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.